文献
J-GLOBAL ID:201802278718890328
整理番号:18A2080668
高度に催吐性の化学療法および造血細胞移植レジメンを受けている血液悪性腫瘍患者における化学療法誘発悪心および嘔吐の予防のためのホザプレピタント,オンダンセトロン,デキサメタゾン(Fond)およびFond+オランザピン(Fond-O)の無作為化プラセボ対照第III相試験: FOND-O試験【JST・京大機械翻訳】
Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Highly Emetogenic Chemotherapy and Hematopoietic Cell Transplantation Regimens: The FOND-O Trial
著者 (7件):
Clemmons Amber B.
(Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Augusta, Georgia)
,
Clemmons Amber B.
(Department of Pharmacy, Augusta University Medical Center, Augusta, Georgia)
,
Orr Julianne
(Department of Pharmacy, Indiana University, Indianapolis, Indiana)
,
Andrick Benjamin
(Geisinger Enterprise Pharmacy, Center for Pharmacy Innovations and Outcomes, Danville, Pennsylvania)
,
Gandhi Arpita
(Department of Pharmacy, Augusta University Medical Center, Augusta, Georgia)
,
Sportes Claude
(Department of Medicine, Division of Hematology and Medical Oncology, Augusta University Medical Center, Augusta, Georgia)
,
DeRemer David
(Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Gainesville, Florida)
資料名:
Biology of Blood and Marrow Transplantation
(Biology of Blood and Marrow Transplantation)
巻:
24
号:
10
ページ:
2065-2071
発行年:
2018年
JST資料番号:
W1625A
ISSN:
1083-8791
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)